Oxindole-benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation. [PDF]
Abdel-Mohsen HT.
europepmc +1 more source
Nanomaterials for liver cancer targeting: research progress and future prospects. [PDF]
Xu J, Liu Y.
europepmc +1 more source
Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine. [PDF]
Nössing C +4 more
europepmc +1 more source
Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls. [PDF]
Ziemba B, Lukow K.
europepmc +1 more source
Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme. [PDF]
Liu X +6 more
europepmc +1 more source
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma. [PDF]
Brunelli M +20 more
europepmc +1 more source
Cartilage organoids from basic research to clinical translation. [PDF]
Zhang W +5 more
europepmc +1 more source
Cytotoxic and senescence-inducing effects of BLU554 in pancreatic ductal adenocarcinoma: an in vitro study. [PDF]
Fujiwara M +8 more
europepmc +1 more source
Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents. [PDF]
Chaudhari PJ, Nemade AR, Shirkhedkar AA.
europepmc +1 more source
The Current Toolbox for Covalent Inhibitors: From Hit Identification to Drug Discovery. [PDF]
You M, Liu H, Li C.
europepmc +1 more source

